The new rule doesn’t change much from what the Trump Administration made a priority in early 2025. The Made in America Office stopped issuing waivers without a detailed review. The main issue for the nitrile glove industry is that the USG only directly purchases about 1.3B gloves per year, only about 1% of the 120B we use annually. A modern high speed line glove factory typically produces 3B-4B gloves annually and you don’t achieve real economies of scale until you’re producing about 10B gloves annually. We need the 232 tariffs in place and the higher Medicaid/Medicare reimbursements to show investors a large demand signal for domestic production. Also need the Strategic National Stockpile to replace the 4B EXPIRED gloves in its inventory and expand it to 12B gloves to have a 30 day supply for pandemic emergencies. Having a requirement for DoW contractors to use US made gloves is also an easy way to increase demand. The majority of manufacturing for DoW items require nitrile gloves (energetics, aerospace parts, composite materials, batteries, magnets, REEs, etc). We don’t want our critical production shut down because we import 99% of our glove needs.